Mainstream conventional oncology experts focuse more on symptomatology, in controling symptoms rather than in finding the root causes and fixing the immune system, the diet, the home environment and all of the other more holistic aspects of the disease. One of the reasons for this approach is based on the postulate that cancer is a genetic disease. .
While holistic science experts don’t negate the importance of the genome, the focus is more on the metabolic, epigenetic, microbiota, emotional and social aspests of the disease, the “downstream” genetic mutations of which come after metabolic alterations and lifestyle aberrations.
By assuming that cancer is essentially a genetic process, targeting tumors and growth factors with toxic therapies becomes the golden standard of care.
On the contrary, ACR Institute’s team believes that genetic deviations constitute epi-phenomena that result from metabolic, microbiota and mitochondrial dysfunctions, most of which can be addressed via corrective holistic techniques, with on rare occasions, the help of adjunctive pharmaceutical bio-tech and neutraceutical interventions for the tough cases that don’t resolve holistically.
Regarding praxis, clinical orientation, the ACR Institute’s team examines all credible experimentation and trials with conventional, integrative and holistic oncology groups from all over the world including, but not limited to European, American, Asian and Mexican clinics.
In this perspective, the ACR Institute’s team has determined that to correctly identify the structural causes and the concomitant solutions to the cancer challenge, the following fields of heuristic inquiry are necessary: metabolic detoxification, metabolic-based cellular respiration, glycolysis, immnuno-boosting therapy, microbiota diversity activation, cancer stem cell science, genetic damage repair (of both cancerous and non cancerous DNA), the inflammation drivers, neuro-science, epigenetics, lifestyle medicine, psycho-neuro-immunology, longevity genes, stem cell biology, telomere science and anti-fungals. The link on the ACR Institute’s cancer protocol approach details a few of these holistic techniques.
When these pathways are holistically addressed, and if the patients has not been irreversiably damaged by conventional oncology, we can then expect a “NED” (no evidence of disease) verdict. Cancer medicine being personalized and a function of the patient’s compliance and genome, there can be no guarantees. But in general, our experience is that most cancer patients have a strong potential to holistically reverse their cancer disease.